Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
NO. THE NAME 103 104 105 TITLE DEPARTMENT YEAR NO.S SUPERVISERS Clinical Patology P.Moushira F.El-Seify 2006 (M.D.) p.Maha S. Madbuly p.FatenH.elMahalawy MahmoudM.Kamel Chronic B-Lymphocytic Leukaemia:Immunoregulatory moleCules,Antigen Experienced Bcells, & Nurse – Like Cells Reham ahmed Morphologic changes &alteration Clinical Mohamed rashed of p53,CD34 evolution pathology accelerated (M.D. Phase of cml:an E.M.,molecular, Cytogenetic &F.C.M.studies. Gamal thabet ali ebid 106- Hisham Abd El- 497 p.Amira khorshed p.Khaled m. aboulenein p.Amira soliman 2006 506 Single nucleotide polymorphism in selected genes involved pathogenesis pediatric acute lymphoblastic leukemia Clinical pathology (M.D.) p.Azza kamel p.heba moussa 2006 508 Expression BCR/ABL Fusion Clinical p.Magda M,assem 2007 522 aziz morsi 107- Abdallah yehya mamdoh habib 108- Eman mahoud samy abu sinna Transcript &its product protein p210,in cell derived patients chronic Myeloid Leukemia (CML),denovo&after treatment Prognostic importance of cytogenetic subgroups among Egyptian childhood,anll The application of REAL/WHO classification of non hodgin’s lymphoma to cytological aspirates a cutomorphologic , immunocytochenical and molecular study pathology (M.D) p.Nayera H.Elshakankiry p.sonya f.arsanyos p.nahla a. bahgat Clinical pathology (PH.D) p.Farida hassan 2007 p.Mohamed hany p.Mohamed ahmed M. Clinical pathology (M.D) p.Emad el-din hamaza p.ahmed abdel warth 2006 p.tarek M.mansour 540 544 109- Ahmed asaad abdel Comparative Sensitivity of Clinical megeed prognostic markers in relation to pathology aggressive types of acute myeioid (M.D) leukemia and myelodysplastyic syndrome. p.Heba M Rabia alZawahry. P.Farida HGad Allah. p.Khaled M AboulEnein. 2007 547 110 Maha sallam M.S. Survivin expression in lymphoma Clinical in egypt. pathology (M.D) p.Magda M.Assem p.Magda Mourad p.Gehan A.Basset 2008 557 111 Rabab afifi M. P53 dysfunction in chronic lymphocytic leukemia Clinical pathology (M.D) p.Amr zeyada p.Osman m.mansour p.Sonya fahmy p.Hisham m.shaheen 2007 573 112 Reham aly abbass elshemy Study of some antioxidants in breast cancer Clinical pathology (M.D) p.Samia akel p.Hussein Khaled p.Hala M.R.H. 2008 579 113 Magda roshdy tadrous Virues as risk factors in lymphomas Clinical pathology (M.D) p.Amira Khorshed p.Nadia Mokhtar p.Sohair abdel-latif 2009 590 114 Nevine Fawzy Shafik Comparative evaluation of the bladdar cancar antigen and telomerase activitu in the detection of primary and recurrent bladder tumor CLINICAL PATHOILOGY (M.D) P.MOH.NASRAT P.ABD RAH.ZKRY P.AMYR ATTIA. 2009 597 115 Eman Mohammed Abdel Aziz Gafaar Promyelcoytic leukmaia:MRD Detection&its correlation With Clinical Outcome CLINICAL PATHOILOGY (M.D) P.Farida gad alla p.Thoraya M.abd Elh. p.Heba Raslan 2009 596 116 Nagwa Rmaadan Abdel-Wadoud Expression of Complement Clnical Regulatory Proteins on Adult Pathoilogy Non Lyphold Leukmia:lmpact on (M.D.) induction of Remission P.Azza M.Kamel 2009 p.Hossam K.Mahmod p.Nahla M.El-sharkaw 602 117 Doaa Ahmed ELAwady Therapy Associated Viral Clnical Infection In Lmmunocmpromised Pathoiogy Children With Acute (M.D.) Lymphoblastic Leukemia P.Sohair Abd El-latif p.Amira Hanafy p.Emad Nabil Edied 2009 605 118 Hala Mohamed El- Evaluation Of Bone Marrow Clnical Negily Abd El-Al Biopsy In The Detection OF Pathoiogy Micrometaes In BREAST Cancer (M.D.) p.Amira Mokhter p.Mohamed Ahmed p.Amr Zaher 2009 619 118 Samah Mohamed Saied Ahmed 119 Alloimmunization Aion After Repeted Blood Transfusion in Cancer Patients Clinical Pathology (M.D.) P.Soher Abdel-Latif 2006 P.Nayera El-Shakank. P.Randa Abo El Feto. 606 Hala Mohamed El- Evaluation of Bone Marrow negily Abd El-Al Biopsy in the Detecton of Micrometastases in Breast Cancer Clinical Pathology (M.D.) P.Amira Khorshed P.Mohamed Abd ElRahman P.Amr El-Sayed Zaher 2009 619 120 Essam Hamed Elnoshokaty Clinical pathology (M.D.) p.Farida Hassan Gab. 2009 p.Sherine Ibrahem pYasser Ahmed Salla. 631 121 Dalia Ahmed Abou Screening For Early Detection Of Clinical El-Azm Colorectal Cancer pathology (Egyptian Experience) (M.D.) p.Mohamed Sherif 2010 p.Nadia Mokhtar p.Soheir Abd EL-Latif 634 FMS Like Tyrosine Kinase 3(flt3)gene Mutations in Acute Myeloid Leukemia (AML)in Patients With Low or Intermediate Risk Karyotypes 122 Eman Kamal A.El fattah Role of Cytokines in Graft Versus Host Disease after peripheral Blood Stem Cell Transplantation (PBSCT) Clinical pathology (M.D.) p.Azza M. Kamel 2010 p.Hussam M.Kamel p.Nahla M.El sharkaw 639 123 Roxsan Ezzat Shafik Expression of PRAME gene in Clinical acute myeliod leukemia and pathology correlation with clinical response. (M.D.) P.Amira Khorshed 2010 P.Magda Assem P.Nahed Abdel wahab 640 124 Naglaa Moustafa Hassan Differntial Expression of Focal adhesion Kinase and IL-3Ra in Acute Myeloid Leukemia Clinical pathology (M.D.) p.Nayera Hamdy p.Nahed abd elwahab p.Ghada Ibrahim p.Gamal M.Abd El. 2010 656 125 Al shaymaa Ahmed Ibrahim Circulating Endothelial Cells in Acute Myeloid Leukemia Clinical pathology (M.D.) p.Khaled Moustafa I. p.Shadia Hasan R. p.Nahed Abdel Alw. 2010 661 126 Rania Salah Ab.Az Role of cd86 &Vascular Endothelial Growth Factor in Acute Myeloid Leukemia Clinical pathology (M.D.) p.Magda M.A.Assem p.Basma M.Elgamal p.Sherine I.Salem 2009 669 127 Omnia M.Badawi Evaluation of FISH for diagnosis Clinical and detection of recurrence of pathology bladder transitional cell (M.D.) carcinoma P.Soheir Shoman P.Ahmed Fahmi P.Naglaa AbdelReheem 2011 681 128 Yomna M.ElMeligui Expression of chemokine(MCP- Clinical 1)and chemokine pathology receptors(CXCR4,CCR2)in acute (M.D.) myeloid leukemia P.Magda Assem P.YasserH.El-nahass P.Heba Raslan 2011 683 129 Fatma Abd AlHafiz Mokhtar Interlekin-3 Receptor Alpha Chain as a Unique Marker for Leukemic Stem Cells in Acute non-Lymphatic Leukemia Clinical P.Amira Mokhtar 2011 Pathology (ph.d.) P.Khaled M.Ab. Enei. P.Osmn M. M. P.Nahla M.El. 687 130 Eman Zaghloul Kandeel Flow Cytometeric Detection of Minimal Residual Disease (MRD)in acute Leukemia:Correlation to Other Prognostic Parameters Clinical P.Azza M. K. Pathology(M.D.) P.Alaa M.El H. P.Nahla M.El. P.Heba S. 690 2011 131 Noha Hassan Study Of Genetic Polymorphism In Aurora A A As A Risk Factor In Breast Carcinoma 132 Nermine Hassn 133 Abeer Salah Elsayed 134 Clinical P.Samia Y. Akil Pathology(M.D.) P.Magdy M. Saber P. Gamal Thabet Ali 2009 708 Possible Role Of Mdm2, P53 and Clinical P. Khaled Mostafa P21 Gene Polymorphism IN The Pathology(M.D.) P. Iman Sedhom Pathogenesis Of Acute Myeloid P. Basma Mostafa Leukemia 2012 714 Moleclar Detection of Cytokeratin-19 mRNA Positive Cell in Peripheral Blood of Breast Cancer Patients Clinical P.Niveen M.El-Hifna Pathology(Ph.D) P.Amany M.Helal P.Amal Fawzy M. P.Iman Loay H. 2012 718 Eman desouky taha Passive smoking & glutathione s Clinical p.nelly h. ali el-din transferase (gst)polymorphism in pathology(m.sc.) p.abdel hady a. abdel breast ca. case- control study wahab 2012 726